Want to join the conversation?
Pharma giant $GILD said that the EU has granted authorization to market the once-daily Truvada combined with safer-sex practices to reduce risk of HIV-1 infection among high-risk uninfected adults, also known as pre-exposure prophylaxis (PrEP). Truvada is currently the most prescribed antiretroviral drug in Europe as part of combination therapy.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.